ENDPOINTS

FDA won’t allow Invivyd’s Pemgarda to treat Covid; Antibiotic biotech launches

Plus, news about BioCryst, AN2 Therapeutics, OS Therapies and Eyenovia: FDA is not expanding Invivyd’s Covid-19 EUA: The regulators declined to allow Pemgarda’s existing EUA to include treatment of mild-to-moderate Covid ...

Feb 24, 2025 - 16:39
 0
FDA won’t allow Invivyd’s Pemgarda to treat Covid; Antibiotic biotech launches
Plus, news about BioCryst, AN2 Therapeutics, OS Therapies and Eyenovia: FDA is not expanding Invivyd’s Covid-19 EUA: The regulators declined to allow Pemgarda’s existing EUA to include treatment of mild-to-moderate Covid ...
Read More

Tags:

Previous Article

New Maps of the Bizarre, Chaotic Space-Time Inside Black Holes

Next Article

Why businesses must step up to sustain global civil society

Related Posts

Drug packaging manufacturers brace for impact as EU chemical ban looms

Drug packaging manufacturers brace for impact as EU che...

Feb 20, 2025  0

In single case, spinal muscular atrophy drug given before birth spared baby of symptoms

In single case, spinal muscular atrophy drug given befo...

Feb 20, 2025  0

FDA lifts hold on Entrada's Duchenne drug after two years

FDA lifts hold on Entrada's Duchenne drug after two years

Feb 24, 2025  0